Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
New-Onset Anxiety Linked to Increased Parkinson’s Disease Risk
1
Mins
July 2024
Recent research highlights a significant link between anxiety and the risk of developing Parkinson’s disease in older adults.
Read more
1
Mins
12th October 2016
Paralysed Limb Movement Regained Following Stem Cell Injection
PARALYSIS may no longer be a permanent state for approximately 17,000 new spinal cord injury patients, following the successful experimental treatment of…
3
Mins
21st September 2016
Merck Presents New Data on the Safety and Durable Efficacy of Cladribine Tablets and Advantages of Early Treatment with Rebif® at the 2016 ECTRIMS Congress
Germany, September 12, 2016 – Merck, a leading science and technology company, today announced key symposia and more than 30 presentations of clinical…
1
Mins
25th July 2016
Green Tea Used to Improve Cognitive Function of Individuals with Down’s Syndrome
INDIVIDUALS with Down’s syndrome have for the first time experienced an improvement in cognitive function as the result of receiving daily doses of green…
1
Mins
25th July 2016
Stem Cells Offer Wider Potential After Restoring Motor Functions in Stroke Patients
THE SUCCESS of a small clinical trial using stem cells to restore the motor functions of stroke patients could have wider implications for the treatment…
6
Mins
19th July 2016
World Brain Day 2016 Devoted to the Ageing Brain
London, July 2016 – “It is becoming increasingly clear that neurological disorders, such as stroke and dementia but to name a few, are projected to rise…
6
Mins
10th June 2016
New Janssen Phase 3 Data in Patients with Moderately to Severely Active Rheumatoid Arthritis Shows Sirukumab Significantly Inhibited Radiographic Progression and Improves Signs and Symptoms of Disease
London, United Kingdom, 8 June, 2016 – Janssen Research & Development, LLC (Janssen) announced today results from a pivotal Phase 3 study evaluating…
1
Mins
9th May 2016
‘Leaky’ Vessels Answer to Unresponsive Cancer
PROMISING research, which has implications for the development of treatments for medulloblastoma, the most common brain tumour in children, has emerged…
1
Mins
9th May 2016
Brain Rewiring After Stroke May be Answer to Therapy
RECOVERY following a stroke can be difficult, but a new study gives an insight into potential recovery markers and new treatment options.
Loading posts...
« Previous
1
…
20
21
22
23
24
25
Next »